Ejima, Masaru
Okamoto, Tsukasa
Suzuki, Takafumi
Anzai, Tatsuhiko
Takahashi, Kunihiko
Miyazaki, Yasunari http://orcid.org/0000-0002-9073-9815
Article History
Received: 12 October 2020
Accepted: 14 July 2021
First Online: 19 July 2021
Declarations
:
: This was a clinical, noninterventional, monocentric study. It was performed retrospectively during routine clinical practice without any further consequences for the patients. The present study conformed to the principles of the Declaration of Helsinki and was approved by the institutional review board at Tokyo Medical and Dental University (M2019-206). No administrative permissions and/or licenses were acquired by the team to access the data used in the research. The need to obtain informed consent was waived by the Ethics Committee of Tokyo Medical and Dental University due to the retrospective nature of this study. To adhere to the Ethics Guidelines for Medical and Health Research Involving Human Subjects, we publicly disclosed the details of the implementation of this study to ensure that the subjects had the opportunity to withdraw.
: Not applicable.
: YM received lecture fees from Nippon Boehringer Ingelheim and AstraZeneca. The other authors, including Tsukasa Okamoto, a member of the editorial board for BMC Pulmonary Medicine, declare that they have no competing interests.